UnitedHealth shows signs of turnaround
Digest more
1don MSN
UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs
The nation's largest private insurer expects 2026 adjusted earnings of more than $18.25 per share, up from a previous outlook of greater than $17.75 per share.
UnitedHealth Group is betting big on AI in 2026 — $1.5 billion to be exact. During the company’s Q1 earnings call, leaders fleshed out how that investment is materializing. “Think about it this way: A third of this is explicitly invested into software products and platforms,
UnitedHealth Group stock rose on Tuesday after the health insurer beat Wall Street’s earnings expectations and raised its full-year profit forecast.
Full-year adjusted earnings guidance was updated to greater than $18.25 per share, assuming 2/3 of earnings occur in the first half due to segment weighting and cost ratio trends. Medicare Advantage membership is expected to contract by approximately 1.
UnitedHealth’s stock rose after big profit beat and raised full-year outlook.
After a tough past twelve months that at one point saw the stock down by more than half, UnitedHealth Group (UNH +7.90%) shareholders finally see a light at the end of the tunnel.
UnitedHealth Group is moving up its share repurchase timeline, announcing plans to deploy at least $2 billion in buybacks by the end of the second quarter. The accelerated timeline is well ahead of its original guidance,
UnitedHealth Group (NYSE:UNH) executives said first-quarter 2026 performance came in ahead of internal plans across all major business segments, citing improving pricing discipline, operational execution and early benefits from technology and process changes.
Morning Overview on MSN
UnitedHealth warns Medicare obesity-drug pilot faces major hurdles
For the roughly 15 million Medicare beneficiaries living with obesity, a new class of weight-loss drugs has been tantalizingly close yet frustratingly out of reach. Now the nation’s largest health insurer is making clear that closing that gap will not be simple.
UnitedHealth Group (NYSE:UNH) just earned a strong endorsement from four Wall Street firms following a better-than-expected Q1 2026 earnings report. Argus stepped up with the most significant action,